GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 263 filers reported holding GLOBUS MED INC in Q4 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $65,677,869 | +32.0% | 958,941 | +3.4% | 4.79% | +29.4% |
| Q1 2024 | $49,764,027 | +28.2% | 927,741 | +27.4% | 3.70% | +18.6% |
| Q4 2023 | $38,811,160 | +123.8% | 728,301 | +108.5% | 3.12% | +79.3% |
| Q3 2023 | $17,340,809 | -44.0% | 349,261 | -32.8% | 1.74% | -40.0% |
| Q2 2023 | $30,946,570 | +119.1% | 519,761 | +108.4% | 2.90% | +126.1% |
| Q1 2023 | $14,124,940 | -20.8% | 249,381 | +3.8% | 1.28% | -26.5% |
| Q4 2022 | $17,845,670 | -12.9% | 240,281 | -30.1% | 1.74% | -14.8% |
| Q3 2022 | $20,483,000 | +41.9% | 343,841 | +33.7% | 2.05% | +31.5% |
| Q2 2022 | $14,435,000 | -30.5% | 257,131 | -8.7% | 1.56% | -12.7% |
| Q1 2022 | $20,779,000 | +31.4% | 281,631 | +28.6% | 1.78% | +16.4% |
| Q4 2021 | $15,818,000 | +3.7% | 219,081 | +10.0% | 1.53% | -9.5% |
| Q3 2021 | $15,254,000 | -33.1% | 199,081 | -32.3% | 1.69% | -31.5% |
| Q2 2021 | $22,800,000 | +26.3% | 294,081 | +0.5% | 2.47% | +17.1% |
| Q1 2021 | $18,047,000 | -8.5% | 292,637 | -3.2% | 2.11% | -12.7% |
| Q4 2020 | $19,721,000 | +26.4% | 302,377 | -4.0% | 2.42% | +1.0% |
| Q3 2020 | $15,598,000 | -13.7% | 314,977 | -16.9% | 2.40% | -16.6% |
| Q2 2020 | $18,083,000 | +18.4% | 379,010 | +5.5% | 2.87% | +4.2% |
| Q1 2020 | $15,277,000 | -21.7% | 359,210 | +8.4% | 2.76% | -4.8% |
| Q4 2019 | $19,513,000 | +20.2% | 331,410 | +4.3% | 2.90% | +3.0% |
| Q3 2019 | $16,238,000 | +45.2% | 317,650 | +20.2% | 2.81% | +44.5% |
| Q2 2019 | $11,182,000 | -35.2% | 264,350 | -24.3% | 1.94% | -41.0% |
| Q1 2019 | $17,263,000 | +53.7% | 349,375 | +34.6% | 3.30% | +13.5% |
| Q4 2018 | $11,234,000 | -29.8% | 259,575 | -7.9% | 2.90% | -24.5% |
| Q3 2018 | $15,999,000 | +40.2% | 281,875 | +24.7% | 3.84% | +12.0% |
| Q2 2018 | $11,408,000 | +5.0% | 226,075 | +3.6% | 3.43% | -3.2% |
| Q1 2018 | $10,869,000 | +41.7% | 218,175 | +16.9% | 3.54% | +18.7% |
| Q4 2017 | $7,672,000 | +57.1% | 186,675 | +13.6% | 2.99% | +45.6% |
| Q3 2017 | $4,885,000 | +13.9% | 164,375 | +27.0% | 2.05% | +3.9% |
| Q2 2017 | $4,290,000 | +15.4% | 129,400 | +3.1% | 1.97% | +1.1% |
| Q1 2017 | $3,717,000 | – | 125,500 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,860,000 | $41,980,000 | 4.04% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,010,575 | $22,808,000 | 2.39% |
| Van Berkom & Associates Inc. | 2,187,650 | $49,375,000 | 2.10% |
| Godshalk Welsh Capital Management, Inc. | 78,644 | $1,775,000 | 1.83% |
| Lloyds Banking Group plc | 8,462 | $190,000 | 1.71% |
| OAK RIDGE INVESTMENTS LLC | 2,360,955 | $53,287,000 | 1.38% |
| Copper Rock Capital Partners, LLC | 769,343 | $17,195,000 | 1.12% |
| FALCON POINT CAPITAL, LLC | 322,165 | $7,130,000 | 1.09% |
| KALMAR INVESTMENTS INC /DE/ | 1,037,337 | $23,413,000 | 1.07% |
| RICE HALL JAMES & ASSOCIATES, LLC | 864,719 | $19,517,000 | 1.02% |